X0508 4 2026-02-27 0 0001477449 Teladoc Health, Inc. TDOC 0001375088 Vandervoort Adam C C/O TELADOC HEALTH, INC., 155 E 44TH ST, SUITE 1700 NEW YORK NY 10017 0 1 0 0 CHIEF LEGAL OFFICER, SECRETARY 0 Common Stock 2026-02-27 4 M 0 4418 A 85150 D Common Stock 2026-02-27 4 M 0 5350 A 90500 D Common Stock 2026-02-27 4 M 0 36610 A 127110 D Common Stock 2026-02-27 4 M 0 1510 A 128620 D Common Stock 2026-02-27 4 M 0 1702 A 130322 D Common Stock 2026-03-02 4 S 0 27083 5.117 D 103239 D Restricted Stock Units 2026-02-27 4 M 0 4418 0 D Common Stock 4418 0 D Restricted Stock Units 2026-02-27 4 M 0 5350 0 D Common Stock 5350 21400 D Restricted Stock Units 2026-02-27 4 M 0 36610 0 D Common Stock 36610 73222 D Performance Stock Units 2026-02-27 4 M 0 1510 0 D Common Stock 1510 0 D Performance Stock Units 2026-02-27 4 A 0 5107 0 A Common Stock 5107 5107 D Performance Stock Units 2026-02-27 4 M 0 1702 0 D Common Stock 1702 3405 D Restricted Stock Units 2026-03-01 4 A 0 181661 0 A Common Stock 181661 181661 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on March 19, 2025, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. /s/ Adam C. Vandervoort 2026-03-03